Back to Nodes
market
Ingredient Claim Intelligence
The gap between supplement brands' marketing claims and verifiable human evidence creates a scalable decision service.
78Risingmedium
STATUS active
EVIDENCE 0 records
CREATED 2026-06-20
UPDATED 2026-06-20
LongevitySupplement Industry
Score Breakdown
Momentum
75
Evidence
65
Mispricing
72
Catalyst
70
Strategic
82
Risk Ctrl
68
Why It Matters
Every supplement brand launching a new product needs to know: does this ingredient work, at what dose, for which population, with what claims ceiling? No systematic, commercially-focused evidence service exists for SMBs in this space.
Description
Supplement brands face increasing regulatory scrutiny and consumer skepticism. Most lack access to systematic evidence reviews. A structured service that maps ingredient claims to human clinical evidence — and identifies claim risk — addresses a real commercial need.
Evidence Map (0 records)
No structured evidence attached. High confidence requires ≥2 evidence records.
Catalysts
▸FTC increased enforcement on supplement claims
▸Longevity consumer trend accelerating
▸Brand founders increasingly science-literate
Risks
▲Longevity Atlas may struggle to defend against GPT-based ingredient lookup
▲Evidence quality is hard to communicate to non-scientific buyers
Contradictions
✕Most supplement brands currently don't pay for evidence reviews — they rely on supplier-provided dossiers
Tracking Metrics
→Longevity Atlas 7-day Sprint sales
→Inbound ingredient question volume
→Regulatory enforcement actions
Judgment History (1 entries)
Node Createdv0.12026-06-200 → 78low → medium
Node created from customer question cq_002 (NMN/NAD+ inbound). Medium confidence because real inbound demand validates the need.
Ready to generate an Intel File for this node?
Attach 2 more evidence record(s) before generating.